|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.78 USD | +4.49% |
|
+3.38% | +41.00% |
| 07-28 | William Blair Initiates Rapport Therapeutics at Outperform | MT |
| 06-29 | Rapport Therapeutics, Inc.(NasdaqGM:RAPP) added to Russell 2500 Growth Benchmark | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +4.49% | +3.38% | +2.66% | +29.13% | +41.00% | +188.47% | - | - | - | 1.96B | |
| -0.80% | +5.16% | +4.47% | +18.99% | +6.02% | -0.70% | +13.00% | -19.14% | +212.10% | 48.95B | |
| -3.95% | +14.70% | +23.07% | +50.15% | +5.49% | +24.15% | +5.15% | -4.00% | +206.27% | 40.75B | |
| +6.22% | +1.81% | +2.61% | +33.34% | +141.27% | +419.17% | +647.45% | +570.98% | - | 38.46B | |
| -1.57% | -1.44% | +13.02% | +9.08% | +6.01% | +7.38% | +43.06% | +1.73% | +1,127.44% | 36.38B | |
| +5.56% | +11.70% | +6.03% | -2.21% | +10.22% | +11.64% | +51.50% | -11.63% | +159.73% | 28.45B | |
| -0.39% | -0.63% | -5.87% | +9.46% | - | - | - | - | - | 16.62B | |
| -1.13% | -4.54% | +9.20% | +38.13% | +2.96% | +32.10% | +126.95% | +228.69% | - | 16.33B | |
| -7.10% | -2.81% | -4.71% | +39.89% | -9.16% | -8.80% | -34.35% | -31.96% | +113.12% | 13.65B | |
| -0.06% | +3.75% | +0.06% | +16.23% | +9.94% | +3.81% | +10.08% | -31.97% | +104.50% | 13.56B | |
| -0.08% | +2.32% | +3.45% | +40.52% | +17.62% | +33.16% | +11.46% | -42.34% | +166.83% | 11.31B | |
| 0.00% | +0.36% | +1.95% | +30.21% | +22.48% | +24.81% | -14.04% | -40.25% | +156.29% | 11.22B | |
| +0.09% | -5.24% | -6.06% | +12.49% | -9.88% | +75.57% | +517.88% | +261.06% | +2,514.46% | 10.63B | |
| +0.07% | +0.03% | +1.18% | +62.02% | +77.93% | +257.09% | +547.23% | - | - | 10.08B | |
| -3.25% | -7.67% | +24.47% | +22.86% | +26.66% | +11.90% | +37.29% | -59.07% | - | 9.18B | |
| -1.41% | -4.64% | -32.80% | -28.73% | -32.65% | +22.85% | +33.90% | +43.46% | +82.53% | 8.93B | |
| +1.67% | -3.05% | -6.68% | +32.00% | +37.53% | +142.82% | +389.97% | +77.82% | - | 8.66B | |
| -0.86% | 0.00% | +6.01% | +19.87% | -12.44% | -22.13% | -21.19% | -29.65% | +33.43% | 8.65B | |
| +4.24% | +2.37% | +13.10% | +40.08% | +58.74% | +153.83% | +626.24% | +180.48% | - | 8.55B | |
| +5.75% | -4.54% | -8.08% | -3.48% | +4.41% | +443.82% | +1,993.54% | +31.52% | - | 8.11B | |
| Average | +0.37% | +2.19% | +2.35% | +23.50% | +21.27% | +95.84% | +276.95% | +66.22% | +443.34% | 17.52B | |
| Weighted average by Cap. | +0.21% | +4.98% | +5.36% | +23.96% | +25.29% | +86.34% | +201.55% | +85.05% | +424.61% |
- Stock Market
- Stocks
- RAPP Stock
- Sector Rapport Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
